Allied Biotech Corporation announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was TWD 355.990 million compared to TWD 334.882 million a year ago. Operating income was TWD 66.587 million compared to TWD 57.507 million a year ago. Net income was TWD 13.687 million compared to TWD 42.152 million a year ago. Basic earnings per share from continuing operations was TWD 0.14 compared to TWD 0.44 a year ago.